Clonal heterogeneity in membrane expression of CD5 in a patient with chronic lymphocytic leukemia.
D000951:Antigens, Neoplasm / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism; D000954:Antigens, Surface / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism; D016175:B-Lymphocyte Subsets / Q000187:drug effects / Q000378:metabolism*; D001483:Base Sequence; D018956:CD5 Antigens / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism; D002999:Clone Cells / Q000378:metabolism*; D015331:Cohort Studies; D015973:Gene Expression Regulation, Leukemic; D015326:Gene Rearrangement, B-Lymphocyte, Heavy Chain; D005803:Genes, Immunoglobulin; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis / Q000235:genetics; D007143:Immunoglobulin Heavy Chains / Q000235:genetics; D007135:Immunoglobulin Variable Region / Q000235:genetics; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis; D016415:Sequence Alignment; D012689:Sequence Homology, Nucleic Acid; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D018956:CD5 Antigens; D007074:Immunoglobulin G; D007143:Immunoglobulin Heavy Chains; D007135:Immunoglobulin Variable Region; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D013755:Tetradecanoylphorbol Acetate